SQUAWK/NEWS
Menu
Live News EQUITY L impact

Ascentage Pharma Files 6-K

Ascentage Pharma Group International files 6-K with SEC. Filing details not specified.

ASPI

Filed: 2026-05-28 AccNo: 0001213900-26-061791 Size: 55 KB